Search

everythinglearnresearchcommunity

for

Search:↓

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

The treatment was ineffective in humans.

Scalp basal cell carcinoma may be more aggressive and harder to treat than other types, requiring special attention and further research.

Microneedling for hair loss may cause skin cancer.

Most people with basal cell carcinoma on their head or neck were 60-70 years old, and it often came back even after being fully removed, especially in certain areas and types.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

The review found that basal cell carcinomas on the scalp are not more aggressive than those in other locations.

BerEP4 and CD34 staining can help tell apart tricholemmoma from basal cell carcinoma.

Basal cell carcinomas in mice can start from hair follicle stem cells and other skin cell types, depending on signaling levels.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

Microneedling for hair loss may cause skin cancer.

Certain drugs can cause skin lupus, but stopping the drug usually helps. Vaccines work against smallpox, genital herpes, and a type of human papillomavirus. More frequent light therapy clears psoriasis faster. Certain treatments work for psoriasis and dermatitis. A specific cream effectively treats a type of skin cancer. Low iron levels aren't directly linked to chronic hair loss.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Scalp basal cell carcinoma in Asians is different from facial basal cell carcinoma, with unique features like being more common in younger people and having larger tumors.

Men are more likely to have larger basal cell carcinomas and squamous cell carcinomas, while women have more superficial basal cell carcinomas and tumors on their legs and central face.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Basal cell carcinoma mostly starts from cells in the upper skin layers, not hair follicle stem cells.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

GLI2 increases follistatin production in human skin cells.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Mohs micrographic surgery is effective for early-stage non-melanoma skin cancers on the lips, with basal cell carcinoma more common on the upper cutaneous lip and squamous cell carcinoma more common on the lower vermilion lip.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

595 nm pulsed dye laser is a cost-effective treatment for nonmelanoma skin cancer with a low recurrence rate.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

The document concludes that scalp conditions have various causes and can present in many different ways.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.